May 2014 Issue of MMM

May 2014 Issue of MMM

May 2014 issue

Editor's Desk

One-product wonders

When it comes to the patent cliff, pharma, it seems, is so over it

Digital Edition

Read the complete May 2014 Digital Edition

Click the above link to access the complete Digital Edition of the May 2014 issue of MM&M, with all text, charts and pictures.


The Pharma Report 2014: New Cycle of Life

Patent expiries took their toll but wore off quickly last year, helping nudge growth in prescription drug spend back into positive territory. Marc Iskowitz reports

Loyalty Programs: Attitudes to Co-Pay Cards

Co-pay programs have long divided opinion among stakeholders. Sarah Morgan reports on the findings of three new exclusive mini-surveys of key stakeholders, including suggestions on ...

Health Literacy: The Language of a Blockbuster

Why do some brands flop and others finish first? It could come down to health literacy. But doing it right involves more than just choosing ...

Leadership Exchange: Small Size, Big Prize

An esteemed panel of marketers from small biotech companies discusses the unique challenges and opportunities of bringing novel products to market. James Chase moderates the ...

MM&M Awards: Judging Panel

The 2014 juding panel for the MM&M Awards is a group of esteemed leaders, thinkers and experts who represent a wide range of disciplines within ...

Headliner: Multi-skilled leader's diversity drive

Kimberly Ray, VP, integrated site services, Quintiles

Therapeutic Focus

Therapeutic Focus 2014: Rheumatology

Few autoimmune competitors even come close to commercial stalwarts Humira, Enbrel and Remicade. But as a host of high-science treatments emerge seeking to threaten their ...

Vantage Point

Vantage Point: Determining "fair market value"

Should pharma formulate a super matrix to determine the FMV of research incentives?


Antidote: Sovaldi's sucess story

Every now and then a new drug comes out that dramatically changes the trajectory of a killer disease. Such a drug is Sovaldi, the new ...

In Focus

How serious is India's pharma problem?

Are the Ranbaxy Laboratories and Sun Pharmaceutical recalls of prescription generics isolated incidents, or signs of a pharma culture in which corners are too often ...

Professional Marketing

Agnitio launches Rainmaker marketing tool

The company unveiled the mix-and-match marketing management tool at the Eye for Pharma conference in Barcelona.

Japanese firm Kowa takes up Vascepa marketing slack

Private Japanese company Kowa is bolstering Amarin's sales force by 250

Professional Marketing briefs: May 2014

News on PM Live, Teva and the Wall Street Journal

Med Ed Report

Pharma preps for Sunshine inquiries

Firms are gearing up for the detailed filing of Sunshine data later this year, after which the inquiries and disputes window will begin.

Cardio educational website from Bayer makes its debut

Bayer HealthCare launched an educational website for US physicians about the rare, life-threatening condition chronic thromboembolic pulmonary hypertension (CTEPH).

Med Ed Report briefs: May 2014

News on HHS, ACCME, Haymarket Medical Education and Smith & Nephew

Professional Media

Survey finds pay doesn't make doctors happy

Medscape's survey of over 24,000 physicians found that a paycheck is not necessarily linked to a physician's professional satisfaction.

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.

Professional Media briefs: May 2014

News on BMJ, MedPage Today and John Wiley & Sons

Partner Forum

Can local and global live together?

As brand communications responsibilities shift from local markets to centralized hubs, what will happen to the smaller, local agencies, and what will regionalization mean in ...

Digital Media

Survey shows Pharma digitally failing patients

A study by consulting firm Accenture shows that patients not only expect digital outreach, but that their desire to be engaged is consistently being ignored.

AOL lands J&J marketing vet

Praised for helping navigate the shift by advertisers into digital, media vet Kim Kadlec is leaving pharma for a new role at AOL.

Digital Media briefs: May 2014

News on Tufts University Center for the Study of Drug Development, Mayo Clinic and

Consumer Marketing

AbbVie art gallery: a glimpse into patient POV

AbbVie's "Perspectives—Art, Inflammation and Me," an exhibit centered around inflammatory diseases, looks to offer patient perspective through an artistic medium.

Color keeps GSK generic off the market

GlaxoSmithKline claims that Sandoz needs to change the packaging for its generic Advair.

DDR on DTC: Myrbetriq

Kudos to Astellas and its ­Myrbetriq brand for a DTC campaign that pulls all of DTC's levers.

Marketing Research

Symphony finds Rx hike from Medicaid claims

The Affordable Care Act has spurred double-digit increases in demand for pharmaceuticals, new data suggest.

IMS Health raises $1.3B in NY IPO

IMS Health raised $1.3 billion last month in its New York IPO.

Agency Business

CDM Group elevates Prince to president

CDM, the Omnicom network of healthcare agencies, named Josh Prince, previously the group's chief creative officer, to president. He replaces Carol DiSanto.

Precision for Medicine acquires Hobart Group Holdings

Precision for Medicine has acquired Hobart Group Holdings, which specializes in strategic communications that address payer needs.

Agency Business briefs: May 2014

Newson ID Media, Frontline Medical Communications and ContextMedia

Beltway Insider

As I See It: FDA's social-media moves

FDA has insisted that its antique regulations can address every new promotional challenge

It's time to replace the FDA, says Newt Gingrich

Former Speaker of the House and presidential candidate Newt Gingrich has declared that it's time to replace FDA


The way to make your physician target list pay off

Specialty brands ignore more than 50% of the specialists they serve, so 50% of the audience is wide open

Keeping "glitch happens" from happening to you

You have to approach quality assurance as an intrinsic part of the process, not an afterthought

Private View

Private View: Testimonials That Get Real

How can testimonials make their mark in a branded space? By getting real.

Upward Move

Upward Move: Pam Hamlin

Pam Hamlin, Global president, Arnold Worldwide

At Work With

At Work With: Jen Jonsson

Jen Jonsson, Director, Operations, Cambridge BioMarketing


People Moves: May 2014

Promotions and hires for manufacturers and agencies

Back Talk

Popping the digital bubble

A general consensus is that a "shake-up" of some kind is coming

Skill Sets (advertising section)